Funding

SECTION I: ESTIMATION OF COSTS

1

Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
… in terms of IPR protection
Minimum spending of 60.000,00 € / year for the safety of the workplace and personal.
…in terms of product development
€ 925,000.00 would be needed for further development of the material including the analysis and testing to become more competitive at a European level.
…in terms of mass production
€5.550.000,00 in a80% to put into production and 20% for management costs
… in terms of marketing
A minimum of € 250,000.00 / year since the product will be sold on the open market, which requires a wide coverage to get the necessary visibility of the product.

 

2

Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs

Year 1

Year 2

Year 3

Year 4

Year 5

Fixed costs

155.000,00€

157.000,00€

167.000,00€

189.000,00€

125.000,00€

Personnel

950.000,00€

940.000,00€

940.000,00€

890.000,00€

890.000,00€

Other running costs

5.950.000,00

5.320.000,00€

4.695.000,00€

4.058.000,00€

3.826.000,00€

Marketing costs

220.000,00€

112.000,00€

112.000,00€

98.000,00€

95.000,00€

TOTAL EXPECTED COSTS

7.275.000,00€

6.529.000,00€

5.914.000,00€

5.235.000,00€

4.936.000,00€

Price per Unit

Type of Unit

Number of Units

TOTAL Expected Revenues

10.103.000,00€

9.390.000,00€

8.250.000,00€

7.150.000,00€

6.500.000,00€

CASH FLOW REQUIRED (REVENUES-COSTS)

2.828.000,00€

2.861.000,00€

2.336.000,00€

1.915.000,00€

1.564.000,00€

TOTAL CAPITAL required for five years

1.350.00,00€

SECTION 2: QUALITATIVE FACTORS

4

Dimension of identified target groups
90% private, 10% government.

 

6

Evaluation of financial Risks for R&D result
The project PROGIMM “ICT technology for immersive multi-sensory design”, with a value exceeding EUR 5 million, was submitted in response to DM No. 1621/Ric. July 18, 2005 as part of the Great Strategic Programmes – PNR2005-2007.

SECTION 3: IDENTIFICATION OF FINANCING SOURCES

  1. 1.  European Funding

Define relevance of the product with the following potential funding sources and comment

2. National Funding

3. Private funding

4. Other

 

SECTION 3: FINAL EVALUATION

It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…

 

  Decision of evaluation (Please tick  as appropriate)

The R&D has a high potential of exploitation

X

The R&D result needs minor revisions

The R&D result needs moderate revisions

The R&D result needs major revisions

The R&D result has no potential of exploitation

Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project